UK Approves Zanidatamab for Advanced HER2-Positive Biliary Tract Cancer
Adults in the UK living with advanced biliary tract cancer now have a new treatment option after the Medicines and Healthcare products Regulatory Agency (MHRA) approved zanidatamab, also known as…